In our study, NAMPT inhibitors were used to suppress the growth of anaplastic meningiomas; at the same time, the expression of PD-L1 and B7-H3 was reduced, which means that FK866 can improve the tumor microenvironment and inhibit immune escape. Here, NAMPT is linked to meningioma.